by - November 1, 2021 10:18 am
UAMS startup lands $13.8 million grant for Phase 2 trial to help meth addicts
University of Arkansas for Medical Sciences startup InterveXion Thearapeutics has been awarded a $13.8 million grant from the National Institutes of Health to fund a three-year Phase 2 clinical trial…